These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2147596)

  • 21. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
    Suzuki K; Vanier MT
    Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.
    Akerman BR; Zielenski J; Triggs-Raine BL; Prence EM; Natowicz MR; Lim-Steele JS; Kaback MM; Mules EH; Thomas GH; Clarke JT
    Hum Mutat; 1992; 1(4):303-9. PubMed ID: 1301938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
    Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
    N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplexed fluorescence analysis for mutations causing Tay-Sachs disease.
    Stockley TL; Ray PN
    Methods Mol Biol; 2003; 217():131-41. PubMed ID: 12491928
    [No Abstract]   [Full Text] [Related]  

  • 26. Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation.
    Paw BH; Neufeld EF
    J Biol Chem; 1988 Feb; 263(6):3012-5. PubMed ID: 2449434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.
    Cecchi AC; Vengoechea ES; Kaseniit KE; Hardy MW; Kiger LA; Mehta N; Haque IS; Moyer K; Page PZ; Muzzey D; Grinzaid KA
    Mol Genet Genomic Med; 2019 Aug; 7(8):e836. PubMed ID: 31293106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primer system for single cell detection of double mutation for Tay-Sachs disease.
    Liu MC; Drury KC; Kipersztok S; Zheng W; Williams RS
    J Assist Reprod Genet; 2000 Feb; 17(2):121-6. PubMed ID: 10806593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Picture of the month. Tay-Sachs disease.
    Arisoy AE; Ozden S; Arisoy ES; Kocabay K; Guvenc H; Tunnessen WW
    Am J Dis Child; 1992 Jun; 146(6):767-8. PubMed ID: 1534438
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
    Guetta E; Peleg L
    Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group.
    Myerowitz R
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3955-9. PubMed ID: 3375249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
    Colaianni A; Chandrasekharan S; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.
    Landels EC; Ellis IH; Bobrow M; Fensom AH
    J Med Genet; 1991 Feb; 28(2):101-9. PubMed ID: 1825851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
    Navon R; Proia RL
    Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium treatment rescues dysfunctional autophagy in the cell models of Tay-Sachs disease.
    Basirli H; Can M; Sengul T; Seyrantepe V
    Mol Genet Metab; 2024 Mar; 141(3):108140. PubMed ID: 38262289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tay-Sachs disease as a model for screening inborn errors.
    Blitzer MG; McDowell GA
    Clin Lab Med; 1992 Sep; 12(3):463-80. PubMed ID: 1355703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical Issues with Genetic Testing for Tay-Sachs.
    Clayton T
    J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PCR analysis of hair root specimens to detect Tay-Sachs disease carriers in Ashkenazi Jews.
    Brillante R; Yang V; Proos A; Burnett L
    Clin Chem; 1995 Feb; 41(2):321-2. PubMed ID: 7874790
    [No Abstract]   [Full Text] [Related]  

  • 39. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.
    Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M
    J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.